0001927425-22-000003.txt : 20220513 0001927425-22-000003.hdr.sgml : 20220513 20220512180824 ACCESSION NUMBER: 0001927425-22-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220513 DATE AS OF CHANGE: 20220512 EFFECTIVENESS DATE: 20220513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DOSE Therapeutics, Inc. CENTRAL INDEX KEY: 0001927425 IRS NUMBER: 871666442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-445465 FILM NUMBER: 22919405 BUSINESS ADDRESS: STREET 1: 3060 PEGASUS PARK STREET 2: BUILDING 6 CITY: DALLAS STATE: TX ZIP: 75247 BUSINESS PHONE: 682-428-0043 MAIL ADDRESS: STREET 1: 3060 PEGASUS PARK STREET 2: BUILDING 6 CITY: DALLAS STATE: TX ZIP: 75247 D/A 1 primary_doc.xml X0708 D/A LIVE 0001927425 DOSE Therapeutics, Inc. 3060 PEGASUS PARK BUILDING 6 DALLAS TX TEXAS 75247 682-428-0043 DELAWARE None None Corporation true 2021 Michael Bakes 3060 Pegasus Park Building 6 Dallas TX TEXAS 75247 Executive Officer Blair Lapointe 3060 Pegasus Park Building 6 Dallas TX TEXAS 75247 Director Steven L. Mcknight 3060 Pegasus Park Building 6 Dallas TX TEXAS 75247 Director John Fulton Murray 3060 Pegasus Park Building 6 Dallas TX TEXAS 75247 Executive Officer Director Deepak Nijhawan 3060 Pegasus Park Building 6 Dallas TX TEXAS 75247 Director McHenry T. Tichenor 3060 Pegasus Park Building 6 Dallas TX TEXAS 75247 Director Biotechnology Decline to Disclose 06b true 0001927425-22-000002 2022-04-30 false true false 0 N/A None None None N/A N/A N/A TX TEXAS 75247 CA CALIFORNIA MT MONTANA NJ NEW JERSEY NM NEW MEXICO NY NEW YORK TX TEXAS false 10000000 10000000 0 false 20 0 0 380000 false DOSE Therapeutics, Inc. Michael Bakes Michael Bakes President 2022-05-11